Neurology
 |
|
1 may 2021 09:19:35 |
| Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD (BMC Neurology) |
|
Tweet Choosing a safe disease modifying therapy during the COVID-19 pandemic is challenging. This case series study was conducted to determine the incidence rate and the course of Covid-19 infection in MS/NMOSD pati... |
| 247 viewsCategory: Neurology |
 Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis (Molecular Brain)Morvan syndrome associated with LGI1 antibody: a case report (BMC Neurology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
